Veterinary Vaccines Market - Comprehensive Study Report & Recent Trends

Veterinary Vaccines Market Synopsis:

Veterinary Vaccines Market Size Was Valued at USD 13.68 Billion in 2023, and is Projected to Reach USD 30.96 Billion by 2032, Growing at a CAGR of 9.5 % From 2024-2032.

The Veterinary vaccines market covers the products that vaccinate animals including livestock, poultry and companion animals, as well as developing, manufacturing, and selling these vaccines. They are very vital in sustaining the animal health, production and preventing outbreak of the diseases that could be in transfer from one animal to another or from animal to human.

The Veterinary Vaccines Market is continuously expanding because of the worldwide concern and need for animal protein, growing concern for animal’s health, and the enhancement in the aesthetic of veterinary science. The livestock segment that is likely to grow with the increasing consumption of meat, dairy, and related products forms a large part of the market. . Logging for diseases such as foot-and-mouth diseases, avian influenza, and rabies has become common to enhance the health of herds so as to also boost productivity.

Higher acceptance of pets as companions and growing concern over zoonotic diseases have created the need for companion animal vaccines. Memorandum advances in regulatory measures in relation to mandatory vaccination and increased emphasis on the research and development of new and efficient vaccines are also contributing factors to market growth. Nevertheless, problems like impossibility to develop new vaccines at a reasonable cost and immunization complications due to the necessity to store vaccines at low temperatures and transport them to rural and remote areas remain.

Veterinary Vaccines Market Trend Analysis:

Growing Focus on DNA and Recombinant Vaccines

• The market for veterinary vaccines globally is gradually shifting from traditional MLV to DNA/Recumbent vaccines. These advanced vaccine forms are more effective, safer and have more stability than ordinary vaccines. DNA vaccines induce a long-lived immunity, higher than that induced by traditional techniques, and provide hope in controlling new and resurfacing diseases in animals. In the same way, the recombinant vaccines that are produced based on genetic engineering also attract increasing attention because these vaccines do not have negative effects on the organism and are aimed at specific pathogens. Larger firms have sought to develop these technologies to ensure that they provide improved vaccines for the veterinary industry that continues to expand.

Expanding Livestock Population in Emerging Economies

• Growth outlook in emerging economies is high for the Veterinary Vaccines Market due to growing livestock base and propensity for animal derived foods. South Asian, Latin American, African markets are increasingly urbanizing populations with steadily increasing disposable incomes demanding and able to afford quality meat, milk and eggs. With improved livestock health needs increasing the frequency of vaccinations in an effort to keep Livestock healthy and productive. Other factors contributing to growth prospects in these areas include government support measures in improving livestock health and production, partnership with other stakeholders for vaccines distribution among others.

Veterinary Vaccines Market Segment Analysis:

Veterinary Vaccines Market Segmented on the basis of Type, Application, End User, and Region.

By Type, Companion Animals segment is expected to dominate the market during the forecast period

• The Companion Animals segment is expected to account for the largest share in the Veterinary Vaccines Market throughout the predicted years due to a growing global population owning pets and better awareness about the wellbeing of animals. Inoculation against the illness like the distemper in dogs, leukemia in cats, and rabies is now common among pet owners with recommendation from vet and regulatory bodies. Also, there has been much emphasis on the affection towards animals and has ensured that there is a high expenditure on pet’s health, and that includes vaccination. There is increased emphasis on mainland development of multi-valent vaccines to address the increasing needs in this segment of vaccines, together with the convenience factor of the delivery system of global vaccines.

By Route of Administration, Injection segment expected to held the largest share

• The Injection segment shall be predicted to occupy the largest market share in the Veterinary Vaccines Market because of its efficiency and utilization. This is so because injectable vaccines provide the necessary dosage and elicit an efficient immune response for both production and pets animals. The development more of the needle-free injectors and automation in vaccine delivery systems are further boosting the use of injectable vaccines. Although other methods of administrating vaccine are increasingly being embraced for some uses, injection remains very popular since it has proven to be very effective and has been embraced for years by most veterinarians and animal healthcare givers.

Veterinary Vaccines Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• North America is expected to have the largest share during the forecast period because of the high facilities for animal healthcare and high pet adoption rate. The United States is dominating the region with high veterinary research and development investment, substantial governmental support for the animal health program, and key participants. Increased incidence rates of such diseases and, stringent standards that require livestock and pet immunization are also expected to drive the market’s growth.
• Canada is also an important player in the North America a growing concern for the welfare and health of animals within its population. The increasing number of pet animals and inclination towards pet adoption across the region is again fuelling the veterinary vaccines market due to the availability of sophisticated animal clinics and widespread animal farming in this region. The properly developed distribution system and availability of efficacious vaccines have been the key factors, which helped North American countries became market leaders.

Active Key Players in the Veterinary Vaccines Market:

• Boehringer Ingelheim (Germany)
• Ceva Santé Animale (France)
• Elanco Animal Health (United States)
• Heska Corporation (United States)
• HIPRA (Spain)
• IDT Biologika (Germany)
• Indian Immunologicals Ltd. (India)
• Merck Animal Health (United States)
• Phibro Animal Health Corporation (United States)
• SEPPIC (France)
• Tianjin Ringpu Bio-Technology Co., Ltd. (China)
• Vetoquinol (France)
• Virbac (France)
• Zoetis Inc. (United States)
• Zydus Animal Health (India)
• Other Active Players

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Veterinary Vaccines Market by by Type
 4.1 Veterinary Vaccines Market Snapshot and Growth Engine
 4.2 Veterinary Vaccines Market Overview
 4.3 Porcine
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Porcine: Geographic Segmentation Analysis
 4.4 Poultry
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Poultry: Geographic Segmentation Analysis
 4.5 Livestock
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Livestock: Geographic Segmentation Analysis
 4.6 Companion Animals
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 Companion Animals: Geographic Segmentation Analysis

Chapter 5: Veterinary Vaccines Market by Technology
 5.1 Veterinary Vaccines Market Snapshot and Growth Engine
 5.2 Veterinary Vaccines Market Overview
 5.3 Live Attenuated
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Live Attenuated: Geographic Segmentation Analysis
 5.4 Inactivated
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Inactivated: Geographic Segmentation Analysis
 5.5 Toxoid
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Toxoid: Geographic Segmentation Analysis

Chapter 6: Veterinary Vaccines Market by Route of Administration
 6.1 Veterinary Vaccines Market Snapshot and Growth Engine
 6.2 Veterinary Vaccines Market Overview
 6.3 Injection
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Injection: Geographic Segmentation Analysis
 6.4 Intranasal
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Intranasal: Geographic Segmentation Analysis

Chapter 7: Veterinary Vaccines Market by End-User
 7.1 Veterinary Vaccines Market Snapshot and Growth Engine
 7.2 Veterinary Vaccines Market Overview
 7.3 Hospitals
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Hospitals: Geographic Segmentation Analysis
 7.4 Clinics)
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Clinics): Geographic Segmentation Analysis

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Benchmarking
  8.1.2 Veterinary Vaccines Market Share by Manufacturer (2023)
  8.1.3 Industry BCG Matrix
  8.1.4 Heat Map Analysis
  8.1.5 Mergers and Acquisitions  
 8.2 BOEHRINGER INGELHEIM (GERMANY)
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Role of the Company in the Market
  8.2.5 Sustainability and Social Responsibility
  8.2.6 Operating Business Segments
  8.2.7 Product Portfolio
  8.2.8 Business Performance
  8.2.9 Key Strategic Moves and Recent Developments
  8.2.10 SWOT Analysis
 8.3 CEVA SANTÉ ANIMALE (FRANCE)
 8.4 ELANCO ANIMAL HEALTH (UNITED STATES)
 8.5 HESKA CORPORATION (UNITED STATES)
 8.6 HIPRA (SPAIN)
 8.7 IDT BIOLOGIKA (GERMANY)
 8.8 INDIAN IMMUNOLOGICALS LTD. (INDIA)
 8.9 MERCK ANIMAL HEALTH (UNITED STATES)
 8.10 PHIBRO ANIMAL HEALTH CORPORATION (UNITED STATES)
 8.11 SEPPIC (FRANCE)
 8.12 TIANJIN RINGPU BIO-TECHNOLOGY CO.
 8.13 LTD. (CHINA)
 8.14 VETOQUINOL (FRANCE)
 8.15 VIRBAC (FRANCE)
 8.16 ZOETIS INC. (UNITED STATES)
 8.17 ZYDUS ANIMAL HEALTH (INDIA)
 8.18 OTHER ACTIVE PLAYERS

Chapter 9: Global Veterinary Vaccines Market By Region
 9.1 Overview
 9.2. North America Veterinary Vaccines Market
  9.2.1 Key Market Trends, Growth Factors and Opportunities
  9.2.2 Top Key Companies
  9.2.3 Historic and Forecasted Market Size by Segments
  9.2.4 Historic and Forecasted Market Size By by Type
  9.2.4.1 Porcine
  9.2.4.2 Poultry
  9.2.4.3 Livestock
  9.2.4.4 Companion Animals
  9.2.5 Historic and Forecasted Market Size By Technology
  9.2.5.1 Live Attenuated
  9.2.5.2 Inactivated
  9.2.5.3 Toxoid
  9.2.6 Historic and Forecasted Market Size By Route of Administration
  9.2.6.1 Injection
  9.2.6.2 Intranasal
  9.2.7 Historic and Forecasted Market Size By End-User
  9.2.7.1 Hospitals
  9.2.7.2 Clinics)
  9.2.8 Historic and Forecast Market Size by Country
  9.2.8.1 US
  9.2.8.2 Canada
  9.2.8.3 Mexico
 9.3. Eastern Europe Veterinary Vaccines Market
  9.3.1 Key Market Trends, Growth Factors and Opportunities
  9.3.2 Top Key Companies
  9.3.3 Historic and Forecasted Market Size by Segments
  9.3.4 Historic and Forecasted Market Size By by Type
  9.3.4.1 Porcine
  9.3.4.2 Poultry
  9.3.4.3 Livestock
  9.3.4.4 Companion Animals
  9.3.5 Historic and Forecasted Market Size By Technology
  9.3.5.1 Live Attenuated
  9.3.5.2 Inactivated
  9.3.5.3 Toxoid
  9.3.6 Historic and Forecasted Market Size By Route of Administration
  9.3.6.1 Injection
  9.3.6.2 Intranasal
  9.3.7 Historic and Forecasted Market Size By End-User
  9.3.7.1 Hospitals
  9.3.7.2 Clinics)
  9.3.8 Historic and Forecast Market Size by Country
  9.3.8.1 Russia
  9.3.8.2 Bulgaria
  9.3.8.3 The Czech Republic
  9.3.8.4 Hungary
  9.3.8.5 Poland
  9.3.8.6 Romania
  9.3.8.7 Rest of Eastern Europe
 9.4. Western Europe Veterinary Vaccines Market
  9.4.1 Key Market Trends, Growth Factors and Opportunities
  9.4.2 Top Key Companies
  9.4.3 Historic and Forecasted Market Size by Segments
  9.4.4 Historic and Forecasted Market Size By by Type
  9.4.4.1 Porcine
  9.4.4.2 Poultry
  9.4.4.3 Livestock
  9.4.4.4 Companion Animals
  9.4.5 Historic and Forecasted Market Size By Technology
  9.4.5.1 Live Attenuated
  9.4.5.2 Inactivated
  9.4.5.3 Toxoid
  9.4.6 Historic and Forecasted Market Size By Route of Administration
  9.4.6.1 Injection
  9.4.6.2 Intranasal
  9.4.7 Historic and Forecasted Market Size By End-User
  9.4.7.1 Hospitals
  9.4.7.2 Clinics)
  9.4.8 Historic and Forecast Market Size by Country
  9.4.8.1 Germany
  9.4.8.2 UK
  9.4.8.3 France
  9.4.8.4 The Netherlands
  9.4.8.5 Italy
  9.4.8.6 Spain
  9.4.8.7 Rest of Western Europe
 9.5. Asia Pacific Veterinary Vaccines Market
  9.5.1 Key Market Trends, Growth Factors and Opportunities
  9.5.2 Top Key Companies
  9.5.3 Historic and Forecasted Market Size by Segments
  9.5.4 Historic and Forecasted Market Size By by Type
  9.5.4.1 Porcine
  9.5.4.2 Poultry
  9.5.4.3 Livestock
  9.5.4.4 Companion Animals
  9.5.5 Historic and Forecasted Market Size By Technology
  9.5.5.1 Live Attenuated
  9.5.5.2 Inactivated
  9.5.5.3 Toxoid
  9.5.6 Historic and Forecasted Market Size By Route of Administration
  9.5.6.1 Injection
  9.5.6.2 Intranasal
  9.5.7 Historic and Forecasted Market Size By End-User
  9.5.7.1 Hospitals
  9.5.7.2 Clinics)
  9.5.8 Historic and Forecast Market Size by Country
  9.5.8.1 China
  9.5.8.2 India
  9.5.8.3 Japan
  9.5.8.4 South Korea
  9.5.8.5 Malaysia
  9.5.8.6 Thailand
  9.5.8.7 Vietnam
  9.5.8.8 The Philippines
  9.5.8.9 Australia
  9.5.8.10 New Zealand
  9.5.8.11 Rest of APAC
 9.6. Middle East & Africa Veterinary Vaccines Market
  9.6.1 Key Market Trends, Growth Factors and Opportunities
  9.6.2 Top Key Companies
  9.6.3 Historic and Forecasted Market Size by Segments
  9.6.4 Historic and Forecasted Market Size By by Type
  9.6.4.1 Porcine
  9.6.4.2 Poultry
  9.6.4.3 Livestock
  9.6.4.4 Companion Animals
  9.6.5 Historic and Forecasted Market Size By Technology
  9.6.5.1 Live Attenuated
  9.6.5.2 Inactivated
  9.6.5.3 Toxoid
  9.6.6 Historic and Forecasted Market Size By Route of Administration
  9.6.6.1 Injection
  9.6.6.2 Intranasal
  9.6.7 Historic and Forecasted Market Size By End-User
  9.6.7.1 Hospitals
  9.6.7.2 Clinics)
  9.6.8 Historic and Forecast Market Size by Country
  9.6.8.1 Turkiye
  9.6.8.2 Bahrain
  9.6.8.3 Kuwait
  9.6.8.4 Saudi Arabia
  9.6.8.5 Qatar
  9.6.8.6 UAE
  9.6.8.7 Israel
  9.6.8.8 South Africa
 9.7. South America Veterinary Vaccines Market
  9.7.1 Key Market Trends, Growth Factors and Opportunities
  9.7.2 Top Key Companies
  9.7.3 Historic and Forecasted Market Size by Segments
  9.7.4 Historic and Forecasted Market Size By by Type
  9.7.4.1 Porcine
  9.7.4.2 Poultry
  9.7.4.3 Livestock
  9.7.4.4 Companion Animals
  9.7.5 Historic and Forecasted Market Size By Technology
  9.7.5.1 Live Attenuated
  9.7.5.2 Inactivated
  9.7.5.3 Toxoid
  9.7.6 Historic and Forecasted Market Size By Route of Administration
  9.7.6.1 Injection
  9.7.6.2 Intranasal
  9.7.7 Historic and Forecasted Market Size By End-User
  9.7.7.1 Hospitals
  9.7.7.2 Clinics)
  9.7.8 Historic and Forecast Market Size by Country
  9.7.8.1 Brazil
  9.7.8.2 Argentina
  9.7.8.3 Rest of SA

Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies

Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research